Phase III study of SUN Y7017 (memantine hydrochloride) in patients with moderately severe to severe dementia of the Alzheimer's type

Authors
Category Primary study
Registry of TrialsJapicCTI
Year 2005
This article has no abstract
Epistemonikos ID: dc347072fe59af9c7314a503c46d6c1404a59308
First added on: Jan 21, 2021